Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular … 08/05/2024 majac Heart Disease “Bayer is determined to drive research and innovations that have the potential to become treatment options for diseases with high unmet medical need, … Share on FacebookTweetFollow usSave